Literature DB >> 19211261

Intra-aortic balloon pump induced pulsatile perfusion reduces endothelial activation and inflammatory response following cardiopulmonary bypass.

Francesco Onorati1, Giuseppe Santarpino, Gelsomina Tangredi, Giorgio Palmieri, Antonino S Rubino, Daniela Foti, Elio Gulletta, Attilio Renzulli.   

Abstract

OBJECTIVE: Intra-aortic balloon pump (IABP)-induced pulsatile perfusion has demonstrated that it can preserve organ function during cardiopulmonary bypass (CPB). We evaluated the role of IABP pulsatile perfusion on endothelial response.
METHODS: Forty consecutive isolated CABG undergoing preoperative IABP were randomized to receive IABP pulsatile CPB during aortic cross-clamping (group A, 20 patients) or standard linear CPB (group B, 20 patients) during cross-clamp time. Hemodynamic results were analyzed by Swan-Ganz catheter [mean arterial pressure (MAP), cardiac index (CI), indexed systemic vascular resistances (ISVR), indexed pulmonary vascular resistances (IPVR), wedge pressure (PCWP)]. Inflammatory/endothelial response was analyzed by pro-inflammatory (IL-2, IL-6, IL-8), anti-inflammatory cytokines (IL-10), and endothelial markers [vascular endothelial growth factor (VEGF) and monocyte chemotactic protein-1 (MCP-1)]. All measurements were recorded preoperatively (T0), before aortic declamping (T1), at the end of surgery (T2), 12h (T3) and 24h (T4) postoperatively. ANOVA for repeated measures was used to evaluate the differences of means.
RESULTS: Hemodynamic response was comparable except for higher MAP (p=0.01 at T1) and lower ISVR (p=0.001 at T1, p=0.003 at T2) in group A. No differences were found in perioperative leakage of IL-2, IL-6, and IL-8 between the two groups (within-group p=0.0001 either in group A and group B; between-groups p=NS at 2-ANOVA). Group A showed significantly lower VEGF (between-groups p=0.001 at 2-ANOVA, p=0.001 at T1, T2) and MCP-1 (between-groups p=0.001 at 2-ANOVA, p=0.001 at T1, T2) with higher IL-10 secretion (between-groups p=0.001 at 2-ANOVA, p=0.01 at T1, T2, T3).
CONCLUSIONS: IABP-induced pulsatile perfusion allows lower endothelial activation during CPB and higher anti-inflammatory cytokines secretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211261     DOI: 10.1016/j.ejcts.2008.12.037

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

1.  Effects of cardiopulmonary bypass on lung nuclear factor-kappa B activity, cytokine release, and pulmonary function in dogs.

Authors:  Gaisheng Yang; Xiaodong Xue; Yanying Chen; Zhihong Song; Zhen Jiang; Kejian Hu
Journal:  Iran J Basic Med Sci       Date:  2015-12       Impact factor: 2.699

2.  The outcome of pediatric patients undergoing congenital cardiac surgery under pulsatile cardiopulmonary bypass in different frequencies.

Authors:  Guanhua Li; Wen Jiang; Yu Zhang; Xiaohua Zhang; Jimei Chen; Jian Zhuang; Chengbin Zhou
Journal:  Ther Clin Risk Manag       Date:  2018-09-03       Impact factor: 2.423

3.  Prognostic value of endothelial biomarkers in refractory cardiogenic shock with ECLS: a prospective monocentric study.

Authors:  Tsung-Yu Tsai; Kun-Hua Tu; Feng-Chun Tsai; Yu-Yun Nan; Pei-Chun Fan; Chih-Hsiang Chang; Ya-Chung Tian; Ji-Tseng Fang; Chih-Wei Yang; Yung-Chang Chen
Journal:  BMC Anesthesiol       Date:  2019-05-15       Impact factor: 2.217

4.  Case Report: Emergency CABG Following Failure of PTCA in a COVID-19 Patient.

Authors:  Silvia Romiti; Marco Totaro; Amalia Laderchi; Mariangela Peruzzi; Mattia Vinciguerra; Ernesto Greco
Journal:  Front Cardiovasc Med       Date:  2021-01-11

5.  Arterial Pulsatility Augments Microcirculatory Perfusion and Maintains the Endothelial Integrity during Extracorporeal Membrane Oxygenation via hsa_circ_0007367 Upregulation in a Canine Model with Cardiac Arrest.

Authors:  Guanhua Li; Shenyu Zhu; Jianfeng Zeng; Zhexuan Yu; Fanji Meng; Zhixian Tang; Ping Zhu
Journal:  Oxid Med Cell Longev       Date:  2022-02-18       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.